Channel BannerChannel Banner
vYF8bnmdQfYvYF8bnmdQfY

Ivermectin Evidence with Dr Tess Lawrie

742,023
Socialcounts.OrgEnter Fullscreen (f)
15,189
likes
4,793
comments
daily view 0
monthly view 0

Share

Live Analytics

Comments 0

Ivermectin Evidence with Dr Tess Lawrie Analytics Table

Income Estimates for Ivermectin Evidence with Dr Tess Lawrie

Based on this YouTube video's total view count of 742K views and industry-standard rates, the estimated total earning is $519 - $1.48K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

About Ivermectin Evidence with Dr Tess Lawrie

Explore Ivermectin Evidence with Dr Tess Lawrie with 742,023 views, 15,189 likes, and 4,793 comments. Experience the impact of this video content that has captured audience attention.

Thank you very much Dr. Lawrie. Ivermectin interview, Dr. Tess Lawrie Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance. https://www.researchgate.net/publication/348297284_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance_Latest_version_v12_-_6_Jan_2021 Kory P, Meduri GU, Iglesias J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. 18 Dec 2020. https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf World Health Organization. 21st Model List of Essential Medicines. Geneva, Switzerland. 2019. https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06 Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 Cochrane, 2019. www.training.cochrane.org/handbook. The GRADE Working Group. GRADE [website] 2020 www.gradeworkinggroup.org. Alam MT, Murshed R, Gomes PF, Masud ZM, Saber S, Chaklader MA, Khanam F, Hossain M, Momen ABIM, Yasmin N, Alam RF, Sultana A, Robin RC. Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study https://ejmed.org/index.php/ejmed/article/view/599 Elgazzar A, Eltaweel A, Youssef SA, Hany B, Hafez M and Moussa H. Efficacy and Safety of ivermectin for Treatment and prophylaxis of COVID-19 Pandemic. Res. Square [Internet] 28Dec.2020 https://www.researchsquare.com/article/rs-100956/v3 Chowdhury, ATMM, Shahbaz, M, Karim, MR, Islam, J, Guo, D, and He, SA Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients. https://www.researchsquare.com/article/rs-38896/v1 Podder CS, Chowdhury N, Mohim IS and Haque W. (2020). Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study. IMC Journal of Medical Science. Niaee MS, Gheibi N, Namdar P, Allami A, Zolghadr L, Javadi A, et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-centre clinical trial. Res. Square [Internet] 24Nov.2020 https://www.researchsquare.com/article/rs-109670/v1 Hashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulami AS, et al. Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq. medRxiv [Internet] 2020.10.26.20219345 https://doi.org/10.1101/2020.10.26.20219345 Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int. J. Infect. Disease [Internet] 2Dec.2020. https://www.ijidonline.com/article/S1201-9712(20)32506-6/fulltext Chachar AZK, Khan KA, Asif M, Tanveer K, Khaqan A and Basri R. Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients, Int. J. Sciences [Internet] Nov.2020:31-V1.2 6th January 2021 20 35 https://www.ijsciences.com/pub/article/2378 Cepelowicz Rajter J, Sherman MS, Fatteh N, Vogel F, Sacks J and Rajter JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019. J. Chest [Internet] 27Oct.2020. https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2934898-4 Khan SI, Khan SI, Debnath CR, Nath PN, Al Mahtab M, Nabeka H, et al. [Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.] Archivos de Bronconeumología, 2020. Volume 56, Issue 12, Pages 828-830,ISSN 0300- 2896.Spain. https://doi.org/10.1016/j.arbres.2020.08.007. Gorial FI, Mashhadani S, Sayaly HM, Dakhil BD, AlMashhadani MM, Aljabory AM, et al. Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial).MedRxiv. 2020.07.07.20145979; https://doi.org/10.1101/2020.07.07.20145979 Spoorthi V, Sasank S. Utility of ivermectin and doxycycline combination for the treatment of SARS-CoV-2. International Archives of Integrated Medicine. https://www.iaimjournal.com/volume-7-issue-10- october-2020/ “I can’t keep doing this.” Doctor pleads for review of data during COVID-19 Senate hearing. 8 December 2020. https://www.youtube.com/watch?v=Tq8SXOBy-4w

About YouTube Real-Time View Count

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.

Embed Widget

Parameters:

  • fullscreen=true - Fullscreen counter
  • graph=true - Live graph chart
  • counter=0/1/2 - Select counter (0=likes, 1=views, 2=comments)
URL

Click to copy the embed URL to your clipboard